Ubiquitination of PFKFB4 by CHIP regulates glycolysis and progression in endometriosis
article
OA: closed
CC0
AI-generated summary
The E3 ubiquitin ligase CHIP ubiquitinates and degrades the key glycolytic enzyme PFKFB4, suppressing its activity and thereby regulating endometriosis progression.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Endometriosis is a common estrogen-dependent gynecological disorder characterized by chronic inflammatory responses and frequently associated with clinical infertility. Recent studies have demonstrated that the pathogenesis of this disease is closely linked to dysregulated post-translational modifications. This study focuses on the regulatory role of the ubiquitin-proteasome system (UPS) in endometriosis and, for the first time, reveals the molecular mechanism by which the E3 ubiquitin ligase STIP1 homology and U-box containing protein 1 (CHIP) specifically binds to and ubiquitinates the glycolytic key enzyme 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4), thereby promoting its degradation and modulating endometriosis progression. Notably, PFKFB4 is aberrantly overexpressed in ectopic endometrial tissues, with its lysine 305 (K305) residue identified as the critical ubiquitination site mediated by CHIP. Functional studies demonstrate that CHIP-mediated ubiquitination of PFKFB4 significantly suppresses glycolytic activity and inhibits the invasive and migratory capacities of endometriotic cells. More importantly, we provide the first evidence that the PFKFB4 inhibitor 5-(n-(8-methoxy-4-quinolyl) amino) pentyl nitrate (5MPN) exerts potent therapeutic effects in both in vitro and in vivo experimental models of endometriosis. In summary, this study elucidates the crucial regulatory role of CHIP-mediated PFKFB4 ubiquitination in the metabolic reprogramming of endometriosis while also identifying a novel molecular target for developing ubiquitination-targeted therapeutic strategies.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Funding
- funders
- [{'doi': None, 'name': 'Graduate Student Research Grant from Shandong Second Medical University', 'awards': ['2024YJSCX012']}, {'doi': None, 'name': 'Graduate Student Research Grant from Shandong Second Medical University', 'awards': ['2023YJSCX014']}, {'doi': None, 'name': 'National Natural Science Foundation of Shandong Province', 'awards': ['ZR2024QH019']}, {'doi': None, 'name': 'Foundation of Weifang Kite Capital Scholars', 'awards': ['ydxz2023021']}, {'doi': '10.13039/501100018627', 'name': 'Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China', 'awards': ['2021KJ107']}]
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (96)
- [Advances in Post-translational Modifications and Endometriosis]. via openalex
- AURKA Enhances the Glycolysis and Development of Ovarian Endometriosis Through ERβ via crossref
- AURKA Enhances the Glycolysis and Development of Ovarian Endometriosis Through ERβ via openalex
- AURKA inhibits the decidualization of the eutopic endometrium in endometriosis through nuclear factor-κB p65† via crossref
- Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology via openalex
- Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology via crossref
- CHIP induces ubiquitination and degradation of HMGB1 to regulate glycolysis in ovarian endometriosis via openalex
- CHIP induces ubiquitination and degradation of HMGB1 to regulate glycolysis in ovarian endometriosis via crossref
- Correction: CHIP induces ubiquitination and degradation of HMGB1 to regulate glycolysis in ovarian endometriosis via crossref
- Correction: CHIP induces ubiquitination and degradation of HMGB1 to regulate glycolysis in ovarian endometriosis via openalex
- Current Drug Therapy Recommendations for the Treatment of Endometriosis via crossref
- Current Drug Therapy Recommendations for the Treatment of Endometriosis via openalex
- E3 ubiquitin ligase TRIM24 deficiency promotes NLRP3/caspase‐1/IL‐1β‐mediated pyroptosis in endometriosis via openalex
- E3 ubiquitin ligase TRIM24 deficiency promotes NLRP3/caspase‐1/IL‐1β‐mediated pyroptosis in endometriosis via crossref
- Identification of an Invasive, N-Cadherin-Expressing Epithelial Cell Type in Endometriosis Using a New Cell Culture Model via openalex
- Identification of an Invasive, N-Cadherin-Expressing Epithelial Cell Type in Endometriosis Using a New Cell Culture Model via crossref
- NEK2 promotes the development of ovarian endometriosis and impairs decidualization by phosphorylating FOXO1 via crossref
- NEK2 promotes the development of ovarian endometriosis and impairs decidualization by phosphorylating FOXO1 via openalex
- Ovarian tumorB1-mediated heat shock transcription factor 1 deubiquitination is critical for glycolysis and development of endometriosis via crossref
- Ovarian tumorB1-mediated heat shock transcription factor 1 deubiquitination is critical for glycolysis and development of endometriosis via openalex
- Oxidative phosphorylation inhibitors inhibit proliferation of endometriosis cells via openalex
- Oxidative phosphorylation inhibitors inhibit proliferation of endometriosis cells via crossref
- PAK5-mediated PKM2 phosphorylation is critical for anaerobic glycolysis in endometriosis via crossref
- PAK5-mediated PKM2 phosphorylation is critical for anaerobic glycolysis in endometriosis via openalex
- Phosphorylation of PFKFB4 by PIM2 promotes anaerobic glycolysis and cell proliferation in endometriosis via crossref
- Phosphorylation of PFKFB4 by PIM2 promotes anaerobic glycolysis and cell proliferation in endometriosis via openalex
- PIM2 Promotes the Development of Ovarian Endometriosis by Enhancing Glycolysis and Fibrosis via openalex
- PIM2 Promotes the Development of Ovarian Endometriosis by Enhancing Glycolysis and Fibrosis via crossref
- Rethinking mechanisms, diagnosis and management of endometriosis via crossref
- Rethinking mechanisms, diagnosis and management of endometriosis via openalex
- SMURF1-mediated ubiquitylation of SHP-1 promotes cell proliferation and invasion of endometrial stromal cells in endometriosis via openalex
- SMURF1-mediated ubiquitylation of SHP-1 promotes cell proliferation and invasion of endometrial stromal cells in endometriosis via crossref
- TRIM59 inhibits PPM1A through ubiquitination and activates TGF-β/Smad signaling to promote the invasion of ectopic endometrial stromal cells in endometriosis via crossref
- TRIM59 inhibits PPM1A through ubiquitination and activates TGF-β/Smad signaling to promote the invasion of ectopic endometrial stromal cells in endometriosis via openalex
- TRIM65 Promotes Invasion of Endometrial Stromal Cells by Activating ERK1/2/C-myc Signaling via Ubiquitination of DUSP6 via crossref
- TRIM65 Promotes Invasion of Endometrial Stromal Cells by Activating ERK1/2/C-myc Signaling via Ubiquitination of DUSP6 via openalex
- Ubiquitin is associated with the survival of ectopic stromal cells in endometriosis. via crossref
- Ubiquitin is associated with the survival of ectopic stromal cells in endometriosis. via openalex
- W2903555655 via openalex
- W2965682141 via openalex
- W3134885188 via openalex
- W3157609181 via openalex
- W3197055771 via openalex
- W4200469063 via openalex
- W4223442146 via openalex
- W4238421997 via openalex
- W4280507347 via openalex
- W4280630823 via openalex
- W4285040131 via openalex
- W4292457593 via openalex
- W4376612781 via openalex
- W4380989942 via openalex
- W4385283921 via openalex
- W4385377592 via openalex
- W4388793838 via openalex
- W4392349459 via openalex
- W4404065672 via openalex
- W4405388972 via openalex
- W6737500823 via openalex
- doi:10.1016/s0140-6736(21)00389-5 via crossref
- doi:10.1016/j.tcb.2013.12.003 via crossref
- doi:10.1038/s41467-022-29442-x via crossref
- doi:10.1016/j.biopha.2023.115190 via crossref
- doi:10.1038/ncb3314 via crossref
- doi:10.1038/s42003-024-07127-z via crossref
- doi:10.1038/s41586-018-0018-1 via crossref
- doi:10.1158/2159-8290.cd-11-0234 via crossref
- doi:10.1186/s40364-022-00376-2 via crossref
- doi:10.7150/ijbs.72842 via crossref
- doi:10.1038/s41419-023-05795-z via crossref
- doi:10.1016/j.molmet.2018.11.013 via crossref
- doi:10.1038/onc.2015.23 via crossref
- doi:10.1038/s41388-019-0898-z via crossref
- doi:10.1210/en.2003-1606 via crossref
- doi:10.1002/ctm2.400 via crossref
- doi:10.1038/s41418-021-00862-4 via crossref
- doi:10.1186/s12943-023-01871-2 via crossref
- doi:10.1038/s41388-018-0386-x via crossref
- doi:10.1074/jbc.m113.508226 via crossref
- doi:10.1038/laban.254 via crossref
- doi:10.1186/s12885-022-09636-8 via crossref
- doi:10.3390/pharmaceutics14010010 via crossref
- doi:10.18632/oncotarget.4534 via crossref
- doi:10.1016/j.isci.2023.107151 via crossref
- doi:10.1016/j.tice.2024.102345 via crossref
- doi:10.1093/cei/uxac072 via crossref
- doi:10.1002/advs.202302025 via crossref
- W1986985221 via openalex
- W2002831680 via openalex
- W2049343607 via openalex
- W2098720660 via openalex
- W2106026436 via openalex
- W2109801386 via openalex
- W2129805026 via openalex
- W2281451846 via openalex
- W2794791791 via openalex
Source provenance
- crossref
- last seen: 2026-05-16T01:00:05.935713+00:00
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-29T00:31:10.604959+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK